iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
58 hedge funds and large institutions have $48.8M invested in iShares Genomics Immunology and Healthcare ETF in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
Holders
58
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.93M | |
| 2 | +$2.13M | |
| 3 | +$1.42M | |
| 4 |
Lido Advisors
Los Angeles,
California
|
+$1.14M |
| 5 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
+$721K |
Top Sellers
| 1 | -$2.66M | |
| 2 | -$700K | |
| 3 | -$218K | |
| 4 |
FHC
First Heartland Consultants
Lake St. Louis,
Missouri
|
-$211K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$118K |